Freyja Healthcare is an early-stage medical device company focused on women’s health, headquartered in Boston. Its centerpiece product is VereSee™, a 2mm safe abdominal access video entry device for laparoscopic surgery. The company plans initial commercialization of VereSee soon with broad availability expected in the second half of 2024. Freyja says it has four products in advanced stages of development alongside 17 granted patents and 21 pending patents. The company intends to use new funding to accelerate product development, propel VereSee commercialization, and advance its offerings in the women’s health market. Leadership is led by Jón Ívar Einarsson and Gaby Moawad.

Total raised

$8M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2024